$59.38
1.923.34%
At close: -
Novonesis (Novozymes) B reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novonesis (Novozymes) B using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-01 | $0.36 | $0.44 | -18.2 % |
Sep 2023 | 2023-10-26 | $0.49 | $0.42 | 16.7 % |
Jun 2023 | 2023-08-09 | $0.32 | $0.42 | -23.8 % |
Mar 2023 | 2023-04-26 | $0.41 | $0.44 | -6.82 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-01 | $664.23M | $674.70M | -1.55 % |
Sep 2023 | 2023-10-26 | $650.51M | $634.28M | 2.56 % |
Jun 2023 | 2023-08-09 | $616.52M | $632.02M | -2.45 % |
Mar 2023 | 2023-04-26 | $666.31M | $662.60M | 0.56 % |
Novonesis (Novozymes) B (NVZMY) is scheduled to report earnings on February 15, 2025. The last reported earnings were for reported on August 27, 2024 for H1.
The Actual EPS was $0.69, which beat the estimate of $0.00.
The Actual Revenue was $2.1B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.